Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127450112 | 12745011 | 2 | F | 20160912 | 20160915 | 20160922 | EXP | US-CIPLA LTD.-2016US05060 | CIPLA | 0.00 | Y | 0.00000 | 20160922 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127450112 | 12745011 | 1 | PS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | UNK, BID, 10 MID | 78604 | BID | |||||||||
127450112 | 12745011 | 2 | SS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG, QD | 78604 | 10 | MG | QD | |||||||
127450112 | 12745011 | 3 | SS | Cyclobenzaprine | CYCLOBENZAPRINE | 1 | Unknown | UNK, PRN | 0 | ||||||||||
127450112 | 12745011 | 4 | SS | LYRICA | PREGABALIN | 1 | Unknown | 75 MG, BID, TWO CAPSULES | L98316 | 0 | 75 | MG | CAPSULE | BID | |||||
127450112 | 12745011 | 5 | SS | LYRICA | PREGABALIN | 1 | Unknown | 10 MG, BID | L68170 | 0 | 10 | MG | CAPSULE | BID | |||||
127450112 | 12745011 | 6 | SS | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Oral | 10 MG, QD AT NIGHT | 0 | 10 | MG | QD | |||||||
127450112 | 12745011 | 7 | SS | DIAZEPAM. | DIAZEPAM | 1 | Oral | 10 MG, TID | 0 | 10 | MG | TABLET | |||||||
127450112 | 12745011 | 8 | SS | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
127450112 | 12745011 | 9 | SS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | UNK, 1 TABLET, QD | 0 | TABLET | QD | ||||||||
127450112 | 12745011 | 10 | SS | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, 6 HOURLY, PRN | 0 | 50 | MG | TABLET | |||||||
127450112 | 12745011 | 11 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 10 MG, BID | U | 0 | 10 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127450112 | 12745011 | 1 | Depression |
127450112 | 12745011 | 3 | Muscle spasms |
127450112 | 12745011 | 4 | Fibromyalgia |
127450112 | 12745011 | 7 | Anxiety |
127450112 | 12745011 | 8 | Hypersensitivity |
127450112 | 12745011 | 9 | Thyroid disorder |
127450112 | 12745011 | 10 | Pain |
127450112 | 12745011 | 11 | Depression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127450112 | 12745011 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127450112 | 12745011 | Amnesia | |
127450112 | 12745011 | Anger | |
127450112 | 12745011 | Crying | |
127450112 | 12745011 | Depression | |
127450112 | 12745011 | Drug ineffective | |
127450112 | 12745011 | Emotional disorder | |
127450112 | 12745011 | Fatigue | |
127450112 | 12745011 | Feeling abnormal | |
127450112 | 12745011 | Loss of consciousness | |
127450112 | 12745011 | Nervousness | |
127450112 | 12745011 | Pain | |
127450112 | 12745011 | Sedation | |
127450112 | 12745011 | Weight increased | |
127450112 | 12745011 | Weight loss poor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |